FundedIQ
Biotechnology

Centerline Biomedical: Funding, Investors & Team (Sep 2026)

Centerline Biomedical, Inc. was established in November 2014 and depends on innovation created at the Cleveland Clinic. Centerline's main goal is to foster high level route frameworks that at first objective interventional vascular strategies.

www.centerlinebiomedical.com LinkedIn Cleveland, United States 11-50 employees
Biotechnology Health Care Medical Navigation B2B
Total raised
$33.0M
Rounds
1
Latest
Series B
Jun 2022

Centerline Biomedical has raised $33.0M across 1 funding round on record, the most recent a Series B of $33.0M announced in Jun 2022.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Centerline Biomedical Company Profile and Key Stats

Total funding raised
$33.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series B
$33.0M in Jun 2022
Employees
11-50
reported band
Headquarters
Cleveland, United States

Latest funding round on record: Jun 2022.

Centerline Biomedical Funding Rounds

Date
Round
Amount
Series B
$33.0M

Centerline Biomedical Founders and Leadership Team

Name
Role
Contact
Vinod Goel
CEO
Locked

Contact details for the Centerline Biomedical team: 1 of 1 has an email address on file.

Start 14-day free trial →

Centerline Biomedical Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M
4,289
$30M

Centerline Biomedical's latest round of $33.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Centerline Biomedical in Biotechnology and Cleveland

Companies Similar to Centerline Biomedical

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Centerline Biomedical Funding FAQs

What does Centerline Biomedical do?

Centerline Biomedical, Inc. was established in November 2014 and depends on innovation created at the Cleveland Clinic. Centerline's main goal is to foster high level route frameworks that at first objective interventional vascular strategies.

How much funding has Centerline Biomedical raised?

Centerline Biomedical has raised $33.0M across 1 round on record. The most recent is a Series B of $33.0M announced in Jun 2022.

When did Centerline Biomedical last raise funding?

Centerline Biomedical's most recent funding round on record is a Series B of $33.0M, announced in Jun 2022.

Who is the CEO of Centerline Biomedical?

Vinod Goel is listed as CEO at Centerline Biomedical.

Where is Centerline Biomedical headquartered?

Centerline Biomedical is based in Cleveland, Ohio, United States.

How many employees does Centerline Biomedical have?

Centerline Biomedical is in the 11-50 employee band.

How does Centerline Biomedical's funding compare to other Biotechnology startups?

Centerline Biomedical's latest round of $33.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Centerline Biomedical Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Centerline Biomedical is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.